Advair Vs Symbicort: Which Inhaler is Right for Your Asthma or COPD?
Medically reviewed by Lauren Okafor | MD, The Frank H Netter MD School of Medicine, Loyola University Medical Center on March 18th, 2026.
Published on February 13th, 2026. Updated on July 23rd, 2026.
Key takeaways
Key Takeaways
Advair comes in two forms: a dry powder inhaler (Diskus) and a metered-dose inhaler (HFA), while Symbicort is available as a metered-dose inhaler
Both medications combine two types of medicine: an inhaled corticosteroid (to reduce inflammation) and a long-acting bronchodilator (to help open the airways)
Dosing can differ depending on the inhaler type and strength, so itβs important to follow the exact instructions provided by your healthcare provider
Age approvals vary: Symbicort is approved for asthma in children as young as 6 years old, while Advair Diskus may be used in children as young as 4 years old (depending on the formulation and indication)
When managing asthma or chronic obstructive pulmonary disease (COPD), choosing the right inhaler can make a big difference in your daily life. Two commonly prescribed options are Advair and Symbicort. Both help control breathing symptoms and prevent flare-ups, but there are some key differences that may affect which one is best for you. Understanding how they work, how they are used, and who they are approved for can help you and your healthcare provider choose the right treatment.
Understanding the Active Ingredients
Both Advair and Symbicort are combination inhalers, meaning they contain two types of medication that work together. One is an inhaled corticosteroid (ICS), which reduces swelling and inflammation in the airways. The other is a long-acting bronchodilator (LABA), which relaxes the muscles around the airways to make breathing easier.
Advair contains fluticasone (the steroid) and salmeterol (the bronchodilator). Symbicort contains budesonide (the steroid) and formoterol (the bronchodilator). While the specific drugs are different, they work in similar ways to control symptoms and improve breathing over time. Using both types together helps manage both the cause of symptoms (inflammation) and the airway tightening that makes breathing difficult.
Delivery Methods and Inhaler Types
One of the biggest differences between these medications is how they are delivered. Advair is available in two forms: a dry powder inhaler (Diskus) and a metered-dose inhaler (HFA). Symbicort is only available as a metered-dose inhaler.
Dry powder inhalers require you to take a strong, deep breath in to pull the medication into your lungs. Some people find this easier because it does not require timing your breath with pressing the inhaler. However, it does require enough lung strength to work properly.
Metered-dose inhalers release a spray of medication. These require you to press the inhaler while breathing in slowly and deeply. This can take some coordination, but using a spacer device can make it easier and help more medication reach your lungs.
The best option often depends on your comfort, coordination, and breathing ability. Your healthcare provider can help you practice proper technique.
Dosing and Administration Differences
Dosing can vary depending on the inhaler type. Some forms of Advair require one inhalation per dose, while othersβalong with Symbicortβrequire two puffs per dose. All of these medications are usually taken twice a day, about 12 hours apart.
Itβs important to follow your prescribed dosing exactly. Taking too little may not control your symptoms, while taking too much can increase the risk of side effects. Try to take your doses at the same times each day to keep your symptoms well controlled.
Age Approvals and Pediatric Considerations
Age approvals differ between these medications. Symbicort is approved for children as young as 6 years old for asthma. Advair Diskus can be used in children as young as 4 years old, while Advair HFA is typically approved for patients 12 years and older.
For COPD, both medications are generally used in adults only.
In children, correct inhaler use is especially important. Many children benefit from using a spacer with aerosol inhalers to make sure the medication reaches the lungs properly. Caregivers and healthcare providers should help children learn and practice proper technique.
Comparing Effectiveness and Clinical Outcomes
Factor |
Advair Diskus |
Advair HFA |
Symbicort |
|---|---|---|---|
Onset of Action |
15-30 minutes |
15-30 minutes |
15 minutes |
Peak Effect |
1-4 hours |
1-4 hours |
1-3 hours |
Duration |
12 hours |
12 hours |
12 hours |
Inhaler Technique |
Moderate difficulty |
Higher difficulty |
Higher difficulty |
Clinical studies have demonstrated that both Advair and Symbicort are highly effective for managing asthma and COPD symptoms. Head-to-head comparisons show similar effectiveness in terms of lung function improvement, symptom control, and reduction in exacerbations. The choice between medications often comes down to individual patient factors rather than significant differences in therapeutic outcomes.
Some patients may respond better to one medication over another due to individual variations in drug metabolism, inhaler technique, or personal tolerance. This is why healthcare providers sometimes need to try different medications to find the optimal treatment for each patient. The effectiveness of either medication depends heavily on proper inhaler technique and consistent daily use as prescribed.
Frequently Asked Questions
Switching between these medications is possible under medical supervision. Your doctor will consider factors like current symptom control, inhaler preference, and any side effects you've experienced. Never switch medications without consulting your healthcare provider first, as dosing and timing may need adjustment.
Advair Diskus may be easier for elderly patients as it requires less coordination than aerosol inhalers. However, it does require sufficient inspiratory strength. Your healthcare provider can assess your specific abilities and recommend the most appropriate option, possibly including spacer devices for aerosol inhalers.
Cost can vary significantly based on your insurance coverage, pharmacy, and whether generic versions are available. Both medications have generic alternatives that may be more affordable. Check with your insurance provider and pharmacist to compare costs for your specific situation.
Most patients begin to notice improvement within 15-30 minutes of the first dose, with maximum benefits typically achieved after 1-2 weeks of consistent use. However, some patients may experience benefits sooner or may need longer to achieve optimal control. Consistency in daily use is key to effectiveness.
Take the missed dose as soon as you remember, but if it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Never take double doses to make up for missed ones, as this could increase side effects without additional benefits.
The Bottom Line
Both Advair and Symbicort are excellent treatment options for managing asthma and COPD, each offering unique advantages depending on your individual needs and preferences. The choice between these medications often comes down to factors like inhaler type preference, age requirements, dosing convenience, and how well you respond to each formulation. While both medications contain similar types of active ingredients and provide comparable effectiveness, the differences in delivery methods and dosing requirements can significantly impact your treatment experience. Working closely with your healthcare provider to understand these differences and potentially trying different options can help you find the most suitable medication for your respiratory health needs. Remember that consistent daily use and proper inhaler technique are essential for optimal results with either medication. Get started with Doctronic today.
References
U.S. Food and Drug Administration. Advair Diskus Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021077s061lbl.pdf
U.S. Food and Drug Administration. Advair HFA Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021254s029lbl.pdf
U.S. Food and Drug Administration. Symbicort Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021929s021lbl.pdf
Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. https://ginasthma.org/gina-reports/
American Academy of Allergy, Asthma & Immunology (AAAAI). Asthma Medications. https://www.aaaai.org/tools-for-the-public/conditions-library/asthma/asthma-medications
Related articles
Compare your treatment options
Chat Now